Works matching DE "CERTOLIZUMAB pegol"
Results: 110
A real-world retrospective study on biologics utilization in patients with psoriasis in Greece during the period 2015–2020.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 7, p. 1, doi. 10.1007/s00403-024-03147-1
- By:
- Publication type:
- Article
Adoption of newly FDA-approved targeted immunomodulatory therapies by dermatologists: a cross-sectional analysis of Medicare Part D claims from 2013 to 2018.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 3, p. 673, doi. 10.1007/s00403-022-02422-3
- By:
- Publication type:
- Article
Renal sarcoidosis associated with certolizumab pegol treatment for psoriatic arthritis.
- Published in:
- Oxford Medical Case Reports, 2022, v. 2022, n. 12, p. 1, doi. 10.1093/omcr/omac133
- By:
- Publication type:
- Article
Correction: Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2077, doi. 10.1007/s13555-024-01210-3
- By:
- Publication type:
- Article
Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 11, p. 2911, doi. 10.1007/s13555-023-01015-w
- By:
- Publication type:
- Article
Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2).
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Drug Survival of Tumor Necrosis Factor-Alpha Inhibitors and Switched Subsequent Biologic Agents in Patients with Psoriasis: A Retrospective Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 6, p. 1347, doi. 10.1007/s13555-023-00932-0
- By:
- Publication type:
- Article
Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2).
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 1, p. 315, doi. 10.1007/s13555-022-00861-4
- By:
- Publication type:
- Article
Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 9, p. 2087, doi. 10.1007/s13555-022-00775-1
- By:
- Publication type:
- Article
Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 6, p. 1397, doi. 10.1007/s13555-022-00741-x
- By:
- Publication type:
- Article
Back to the Future: Is the Schober Test Dispensable in Juvenile Spondyloarthritis?
- Published in:
- Journal of Rheumatology, 2023, v. 50, n. 4, p. 466, doi. 10.3899/jrheum.221231
- By:
- Publication type:
- Article
Psoriasis: Sind Geschlechtsunterschiede bedeutsam?
- Published in:
- Kompass Dermatologie, 2024, v. 12, n. 4, p. 222, doi. 10.1159/000542073
- By:
- Publication type:
- Article
Rheumatoid faktor és terápiás döntés rheumatoid arthritisben.
- Published in:
- Immunology Quarterly / Immunológiai Szemle, 2024, v. 16, n. 3, p. 45
- By:
- Publication type:
- Article
Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet's Disease †.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 23, p. 7388, doi. 10.3390/jcm13237388
- By:
- Publication type:
- Article
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 4, p. 1630, doi. 10.3390/jcm12041630
- By:
- Publication type:
- Article
Biomarkers and Predictive Factors for Treatment Response to Tumor Necrosis Factor-α Inhibitors in Patients with Psoriasis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 974, doi. 10.3390/jcm12030974
- By:
- Publication type:
- Article
Therapy of PsO in Special Subsets of Patients.
- Published in:
- Biomedicines, 2022, v. 10, n. 11, p. 2879, doi. 10.3390/biomedicines10112879
- By:
- Publication type:
- Article
De-Escalation of Anti-Tumor Necrosis Factor Alpha Agents and Reduction in Adverse Effects: A Systematic Review.
- Published in:
- Biomedicines, 2022, v. 10, n. 5, p. 1034, doi. 10.3390/biomedicines10051034
- By:
- Publication type:
- Article
Systematic review and bayesian network meta-analysis: comparative efficacy and safety of six commonly used biologic therapies for moderate-to-severe Crohn's disease.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1475222
- By:
- Publication type:
- Article
Paradoxical eruption exclusively located on the ear in patients with psoriasis treated with biologics: a case series.
- Published in:
- Clinical & Experimental Dermatology, 2024, v. 49, n. 8, p. 899, doi. 10.1093/ced/llae054
- By:
- Publication type:
- Article
Children With Enthesitis‐Related Arthritis and Possible Benefits From Treatments for Adults With Spondyloarthritis.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 7, p. 1058, doi. 10.1002/acr.24529
- By:
- Publication type:
- Article
Drug Adherence and Persistence of Patients with Moderate to Severe Psoriasis Treated with Biologic Medications in a US Commercially Insured Population.
- Published in:
- Dermatology (10188665), 2022, v. 238, n. 3, p. 438, doi. 10.1159/000519176
- By:
- Publication type:
- Article
Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-52016-4
- By:
- Publication type:
- Article
Real-world retention rates of biologics in patients with rheumatoid arthritis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48537-z
- By:
- Publication type:
- Article
Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37010-6
- By:
- Publication type:
- Article
Comparisons of infection events associated with tumor necrosis factor inhibitors in patients with inflammatory arthritis: A systematic review and network meta-analysis.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1376262
- By:
- Publication type:
- Article
Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1169327
- By:
- Publication type:
- Article
Doporučené postupy České revmatologické společnosti pro farmakologickou léčbu revmatoidní artritidy – aktualizace v roce 2024.
- Published in:
- Czech Rheumatology / Česká Revmatologie, 2024, v. 32, n. 1, p. 7
- By:
- Publication type:
- Article
Vliv pohlaví na závažnost onemocnĕní a terapeutickou odpovĕď u pacientů s revmatoidní artritidou, axiální spondyloartritidou a psoriatickou artritidou léčených jeden rok certolizumab peIolem - analýza z národního registru biologické léčby ATTRA
- Published in:
- Czech Rheumatology / Česká Revmatologie, 2021, v. 29, n. 4, p. 191
- By:
- Publication type:
- Article
Denosumab-induced Acute Generalized Exanthematous Pustulosis.
- Published in:
- Acta Dermato-Venereologica, 2024, v. 104, p. 1, doi. 10.2340/actadv.v104.40430
- By:
- Publication type:
- Article
Interleukin-17 and - 23 Inhibitors Associated with Direct Effects on Depressive Symptoms in Psoriasis: A Register Study.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.7138
- By:
- Publication type:
- Article
Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review.
- Published in:
- PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0293433
- By:
- Publication type:
- Article
Off‐label biologic treatments in refractory inflammatory scarring alopecia.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 8, p. e708, doi. 10.1111/jdv.19851
- By:
- Publication type:
- Article
How to choose a systemic treatment for moderate‐to‐severe nail psoriasis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 12, p. e1034, doi. 10.1111/jdv.18435
- By:
- Publication type:
- Article
Infection risk in psoriatic patients receiving tumour necrosis factor inhibitors: a 20‐year systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 12, p. 2301, doi. 10.1111/jdv.18407
- By:
- Publication type:
- Article
Congenital spilo‐melanocytic nevus: a speckled lentiginous naevus and a spilus‐like congenital melanocytic nevus in close proximity.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 11, p. e926, doi. 10.1111/jdv.18391
- By:
- Publication type:
- Article
Dermatologic inflammatory conditions require high loading and maintenance doses of biologic therapy.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 10, p. e786, doi. 10.1111/jdv.18268
- By:
- Publication type:
- Article
Exploring the impact of the national tender system on the use of costly drugs treating rheumatoid arthritis patients in ten rheumatology centers in Norway (2010–2019).
- Published in:
- BMC Health Services Research, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12913-023-09975-7
- By:
- Publication type:
- Article
Title of presented paper: Therapy in Crohn's disease with two biologic drugs -- a case report.
- Published in:
- European Journal of Clinical & Experimental Medicine, 2023, p. 67
- By:
- Publication type:
- Article
Current usage of and perspectives on the use of MRI to assess treatment non-response in axial spondyloarthritis: a UK-based survey.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 4, p. 1, doi. 10.1093/rap/rkae139
- By:
- Publication type:
- Article
Minimal change nephrotic syndrome due to certolizumab pegol, an anti-tumor necrosis factor-alpha monoclonal antibody for treatment of rheumatoid arthritis.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 1, p. 1, doi. 10.1093/rap/rkac012
- By:
- Publication type:
- Article
Granulomatous Hepatitis Treated With Certolizumab Pegol.
- Published in:
- ACG Case Reports Journal, 2024, v. 11, n. 4, p. 1, doi. 10.14309/crj.0000000000001310
- By:
- Publication type:
- Article
Complex decongestive therapy in hidradenitis suppurativa-related genital lymphoedema: a case report.
- Published in:
- Journal of Wound Care, 2024, v. 33, n. Sup2a, p. xxviii, doi. 10.12968/jowc.2024.33.Sup2a.xxviii
- By:
- Publication type:
- Article
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 3, p. 363, doi. 10.1002/art.42730
- By:
- Publication type:
- Article
Non-Infectious Uveitis and Pregnancy, is There an Optimal Treatment? Uveitis Course and Safety of Uveitis Treatment in Pregnancy.
- Published in:
- Ocular Immunology & Inflammation, 2024, v. 32, n. 8, p. 1819, doi. 10.1080/09273948.2023.2296030
- By:
- Publication type:
- Article
Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2024, v. 63, n. 11, p. 3015, doi. 10.1093/rheumatology/keae435
- By:
- Publication type:
- Article
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2023, v. 62, n. 6, p. 2090, doi. 10.1093/rheumatology/keac564
- By:
- Publication type:
- Article
Clinical efficacy study of abatacept in the treatment of rheumatoid arthritis patients in China.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 10, p. 1, doi. 10.1111/1756-185X.15300
- By:
- Publication type:
- Article
Dengue severity in rheumatoid arthritis patients under treatment with disease‐modifying antirheumatic drugs.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 6, p. 1, doi. 10.1111/1756-185X.15224
- By:
- Publication type:
- Article